发明名称 Use of imidazolinylaminoisoindolines and related compounds for the manufacture of a medicament for the treatment of hyperglycaemia.
摘要 <p>A method for the treatment and/or prophylaxis of hyperglycaemia in human or non-human mammals which comprises administering to the mammal in need of such treatment and/or prophylaxis an effective non-toxic amount of: a compound of formula (I): &lt;CHEM&gt; or a pharmaceutically acceptable acid addition salt thereof, wherein each of R&lt;1&gt; and R&lt;2&gt;, which may be the same or different, represents a hydrogen or halogen atom, or an alkyl or alkoxy group containing 1 to 4 carbon atoms, X represents an oxygen or sulphur atom, an imino group, an acylimino group containing 2 to 4 carbon atoms in the acyl group, or a methylene group, each of n and m, which may be the same or different, represents the number 1, 2 or 3, and p represents the number 2 or 3; with the proviso that when the moiety &lt;CHEM&gt; is present in formula (I), then either R&lt;1&gt; or R&lt;2&gt; must represent hydrogen; or a compound of formula (II): &lt;CHEM&gt; or a pharmaceutically acceptable acid addition salt thereof, wherein each of R&lt;3&gt; and R&lt;4&gt; may be either a hydrogen or halogen atom; or an alkyl or alkoxy group either of which groups may have from 1 to 4 carbon atoms; providing that either R&lt;3&gt; or R&lt;4&gt; must be hydrogen; R&lt;5&gt; and R&lt;6&gt; can be identical or different and either a hydrogen or an alkyl with 1 to 4 carbon atoms, and R&lt;7&gt;, R&lt;8&gt;, R&lt;9&gt;, and R&lt;1&gt;&lt;0&gt; can be identical or different and either hydrogen or an alkyl with 1 to 4 carbon atoms, or in which R&lt;7&gt; and R&lt;8&gt; together represent an ethylene group with the further proviso that when R&lt;7&gt; and R&lt;8&gt; represent an ethylene group then at least one of R&lt;5&gt;, R&lt;6&gt;, R&lt;9&gt; and R&lt;1&gt;&lt;0&gt; represents an alkyl group with 1 to 4 carbon atoms; and compositions for use in such method.</p>
申请公布号 EP0254777(A2) 申请公布日期 1988.02.03
申请号 EP19860305248 申请日期 1986.07.07
申请人 BEECHAM GROUP PLC 发明人 CAWTHORNE, MICHAEL ANTHONY BEECHAM PHARMACEUTICALS
分类号 A61K31/40;A61K31/415;A61K31/42;A61K31/425;A61K31/435;A61K31/47;A61K31/505;A61K31/535;A61K31/54;A61K31/55 主分类号 A61K31/40
代理机构 代理人
主权项
地址